Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual disease. [electronic resource]
Producer: 20040621Description: 1719-25 p. digitalISSN:- 1042-8194
- Aged
- Antibodies, Monoclonal -- immunology
- Antineoplastic Agents -- adverse effects
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Immunoconjugates -- immunology
- Infusions, Intravenous
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm, Residual -- drug therapy
- Prognosis
- Remission Induction
- Ricin -- immunology
- Survival Rate
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.